Does TOPOTECAN Cause Intentional product use issue? 9 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 9 reports of Intentional product use issue have been filed in association with TOPOTECAN (HYCAMTIN). This represents 0.3% of all adverse event reports for TOPOTECAN.
9
Reports of Intentional product use issue with TOPOTECAN
0.3%
of all TOPOTECAN reports
6
Deaths
1
Hospitalizations
How Dangerous Is Intentional product use issue From TOPOTECAN?
Of the 9 reports, 6 (66.7%) resulted in death, 1 (11.1%) required hospitalization.
Is Intentional product use issue Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TOPOTECAN. However, 9 reports have been filed with the FAERS database.
What Other Side Effects Does TOPOTECAN Cause?
Febrile neutropenia (425)
Off label use (390)
Death (332)
Product use in unapproved indication (323)
Neutropenia (255)
Pyrexia (252)
Anaemia (242)
Malignant neoplasm progression (238)
Drug ineffective (216)
Disease progression (207)
What Other Drugs Cause Intentional product use issue?
INFLIXIMAB (11,028)
RITUXIMAB (9,602)
INFLIXIMAB-DYYB (7,549)
TOCILIZUMAB (5,078)
METHOTREXATE (4,087)
PREDNISONE (3,961)
ABATACEPT (3,693)
ADALIMUMAB (3,557)
NIVOLUMAB (3,297)
LEFLUNOMIDE (3,280)
Which TOPOTECAN Alternatives Have Lower Intentional product use issue Risk?
TOPOTECAN vs TOPOTECAN\TOPOTECAN
TOPOTECAN vs TOPROL
TOPOTECAN vs TOREMIFENE
TOPOTECAN vs TORIPALIMAB
TOPOTECAN vs TORSEMIDE